Search research articles
Contact Us
Filters
Showing results (91-100 of 346) with videos related to
Page
of 35
Sort By:
American Journal of Hematology
|
June 7, 2021
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation
Kylee L Martens, Christopher I Amos, Cristhiam Rojas Hernandez, et al.
Cancer Research
|
May 12, 2011
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci
Stefan O Ciurea, Rima M Saliba, Gabriela Rondon, et al.
British Journal of Haematology
|
February 3, 2023
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy
Xin Shelley Wang, Samer A Srour, Tito Mendoza, et al.
Cancer
|
April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia
Hagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 2019
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
David I Marks, Partow Kebriaei, Matthias Stelljes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation
Betul Oran, Piyanuch Kongtim, Uday Popat, et al.
Haematologica
|
March 26, 2026
Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia
Daniel Nguyen, Elias Jabbour, Hagop M Kantarjian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Hans C Lee, Rima M Saliba, Gabriela Rondon, et al.
British Journal of Haematology
|
May 10, 2017
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results
Samer A Srour, Shaoying Li, Uday R Popat, et al.
Page
of 35
Search research articles
Search
Showing results (91-100 of 346) with videos related to
Sort By:
Page
of 35
American Journal of Hematology
|
June 7, 2021
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation
Kylee L Martens, Christopher I Amos, Cristhiam Rojas Hernandez, et al.
Cancer Research
|
May 12, 2011
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci
Stefan O Ciurea, Rima M Saliba, Gabriela Rondon, et al.
British Journal of Haematology
|
February 3, 2023
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy
Xin Shelley Wang, Samer A Srour, Tito Mendoza, et al.
Cancer
|
April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia
Hagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 2019
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
David I Marks, Partow Kebriaei, Matthias Stelljes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation
Betul Oran, Piyanuch Kongtim, Uday Popat, et al.
Haematologica
|
March 26, 2026
Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia
Daniel Nguyen, Elias Jabbour, Hagop M Kantarjian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Hans C Lee, Rima M Saliba, Gabriela Rondon, et al.
British Journal of Haematology
|
May 10, 2017
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results
Samer A Srour, Shaoying Li, Uday R Popat, et al.
Page
of 35